In a non-deterministic, AI-driven architecture, if your security strategy is trying to “catch up,” you’ve already lost.

The Octagon XAI CLO Income Fund is available on platforms under the ticker symbol OCTIX for the Class I share and OCTAX for the Class A share.

In the early 40s, and perhaps even earlier, it is important for women and their health care team to start discussing ...

The thermal utilization of sustainable fuels and the recovery of waste heat play a central role in today’s energy generation ...

HHS’s Health Resources and Services Administration released updated guidance for cervical cancer screening, which includes a ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

What: Ultraviolet observations of the interstellar comet 3I/ATLAS captured by NASA’s Europa Clipper spacecraft while the ...

Scientific uncertainty persists around 3I/ATLAS after anomalous observations and a CIA FOIA response, despite NASA’s public ...

The DMV identified an issue pertaining to how expiration dates were calculated for some of California's residents with legal ...

(HealthDay News) — Zoliflodacin is noninferior to ceftriaxone plus azithromycin for the treatment of uncomplicated urogenital gonorrhea, according to a study published online Dec. 11 in The Lancet.